텍사스의 교모세포종 임상 시험
교모세포종 관련 연구 33개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.
텍사스의 도시
공식 연구 텍스트(영어)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UT MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07326566A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- NEXT Dallas - Oncology Department, Irving
- START | San Antonio, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06914128A Phase I Clinical Study of YN003 in the Treatment of Glioma
- The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07929909Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Houston Methodist, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07195591Anti-GD2 ADC M3554 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06641908A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT05303467A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Baylor Scott & White Research Institute, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05765812Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06810544Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05460507SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- University of Texas Health Mays Cancer Center, San Antonio
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05303519GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Baylor St. Luke's Medical Center, Houston
피험자 모집 중1상
21세 ~ 70세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06815432A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
- Baylor College of Medicine, Houston
피험자 모집 중1/2상
25세 이하 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04094610MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
- M D Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379Targeted Pediatric High-Grade Glioma Therapy
- Texas Children's Hospital, Houston
피험자 모집 중관찰 연구
12 Months – 39 Years · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
36 Months – 22 Years · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
- Texas Children's Hospital, Houston
피험자 모집 중2상
12세 ~ 39세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT06161974A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
- MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07579208Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
- Excel Diagnostics & Nuclear Oncology Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT07733674A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT06672575Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- M D Anderson Cancer Center, Houston
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 7. 20. 업데이트됨 · NCT04479696Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
- M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT04623931DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
- The University of Texas Health Science Center at San Antonio, San Antonio
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT06805305Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Texas Children's Hospital, Houston
피험자 모집 중초기 1상건강한 지원자 환영
1세 ~ 21세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT06333899Imaging Acetadote Metabolism in Glioblastoma
- University of Texas Southwestern Medical Center, Dallas
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07387666Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Texas Children's Hospital, Houston
피험자 모집 중2상
12 Months – 39 Years · 모든 성별 · 2026. 5. 29. 업데이트됨 · NCT05843253HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
- Houston Methodist Neurological Institute, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 30. 업데이트됨 · NCT03603405HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- Houston Methodist Neurological Institute, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 30. 업데이트됨 · NCT03596086Sacituzumab Govitecan in Recurrent Glioblastoma
- Texas Oncology Austin, Austin
- University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 30. 업데이트됨 · NCT04559230SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
- Mays Cancer Center, UT Health San Antonio, San Antonio
피험자 모집 중2상
전 연령 · 모든 성별 · 2025. 8. 27. 업데이트됨 · NCT04863950Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
- UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 6. 25. 업데이트됨 · NCT05879367ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.